Cover image of the article: Ceramide can induce Leukocyte common antigen-related (LAR) gene at mRNA and Protein level in C2C12 muscle cells

Image Credit:Ann Mil Health Sci Res

Ceramide can induce Leukocyte common antigen-related (LAR) gene at mRNA and Protein level in C2C12 muscle cells

Authors

Sattar Gorgani Firozjaei1,*, Akram Nejhadi2, Mohammad Soleimani3, Radina Eshtiaghi4
1Researcher, Department of laboratory sciences, Paramedical faculty, AJA University of medical sciences, Tehran, Iran., Iran
2Researcher, Department of Anatomy, Faculty of Medicine, AJA University of medical sciences, Tehran, Iran., Andorra
3Assistant Professor, Tasnim molecular-biology Research Center, AJA University of medical sciences, Tehran, Iran, Andorra
4Assistant Professor, Department of Endocrinology, Medicine faculty, AJA University of medical sciences, Tehran, Iran, Andorra
*Corresponding Author: Corresponding author: Sattar Gorgani Firozjaei, Researcher, Department of laboratory sciences, Paramedical faculty, AJA University of medical sciences, Tehran, Iran., Iran Email: gorgani59@gmail.com

Annals of Military and Health Sciences Research:Vol. 11, issue 2; e66204
Published online:May 24, 2013
Article type:Research Article
Received:Feb 25, 2013
Accepted:Apr 24, 2013
How to Cite:Gorgani Firozjaei S, Nejhadi A, Soleimani M, Eshtiaghi R. Ceramide can induce Leukocyte common antigen-related (LAR) gene at mRNA and Protein level in C2C12 muscle cells. Ann Mil Health Sci Res. 2013;11(2):e66204. doi:

Abstract

Background: Type 2 diabetes results from two defects, insulin resistance and beta cell dysfunction. At the molecular and cellular levels, there is a connection between fatty acid accumulation and insulin resistance in muscles. Although several mechanisms involved in FFA-induced muscle insulin resistance, the exact mechanism is poorly understood. Recent studies show that the defect in insulin signaling pathway might be underlying mechanism for FFA-induced insulin resistance in the muscle. Protein tyrosine phosphatases like Leukocyte common antigen-related (LAR) are the key elements of insulin signaling and they can be a candidate in FFA induced insulin resistance. Studies have shown that type 2 diabetes involved and obese individuals have had increased levels of LAR in their tissues. However, the responsible factor for LAR overexpression is not well understood. In this study we investigate ceramide effect on LAR expression in the muscle cells.

Materials and Methods: In this laboratory study C2C12 cells (mouse skeletal) after differentiation to myotubes using 2% of horse serum for 4 days, treated with 50 and 100 mMs of C2ceramide for 16h. RNA extracted, cDNA synthesized and Real Time PCR using specific primers for LAR and beta actin used. To detect LAR protein levels western blot was used.

Results: 100 mMs Ceramide (45%, P<0.01) significantly induced LAR mRNA expression but there was not significant difference between 50mM ceramide and untreated cells. The results from real time confirmed by protein data. 100 mMs Ceramide (52%, P<0.01) significantly induced LAR protein levels in comparison of control.

 

Conclusion: The data from this study provide evidence that ceramide around pathologic concentration induce LAR expression. Results supported by human studies that were showed that diabetic and obese persons have a high level of LAR expression and revealed ceramide can be one of the responsible factors for inducing LAR expression in diabetic patients. However, further investigations are needed to clarify exact role of LAR in FFA induced insulin resistance.

Highlights

Fulltext

Full text is available in pdf

References

  • 1.
    References are available in pdf.

Copyright

© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
May
2026
Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights

Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights

Hassan Darvakh

Darvakh H. Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights. Jundishapur J Nat Pharm Prod. 2026;21(2):e171497. doi: https://doi.org/10.5812/jjnpp-171497

28
Dec
2015
Evaluation of MALAT1 gene expression in AML and ALL cell lines

Evaluation of MALAT1 gene expression in AML and ALL cell lines

javad ahmadi,
Saeid Kaviani jebeli,
amir atashi

ahmadi J, Kaviani jebeli S, atashi A. Evaluation of MALAT1 gene expression in AML and ALL cell lines. koomesh. 2015;17(1):e150779. doi:

23
Apr
2019
Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

Shaghayegh Askarian-Amiri,
Farzane Ordoni Aval,
Abbas Azadmehr,
Morteza Oladnabi,
Mahjoobeh Jafari Vesiehsari,
Mahmoud Hajiahmadi

Askarian-Amiri S, Ordoni Aval F, Azadmehr A, Oladnabi M, Jafari Vesiehsari M, et al. Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia. Int J Cancer Manag. 2019;12(4):e87773. doi: https://doi.org/10.5812/ijcm.87773

10
Jan
2023
Upregulation of SNHG7 and FAIM2 Expression Levels in Chronic Myelogenous Leukemia Patients Compared with Normal Subjects

Upregulation of SNHG7 and FAIM2 Expression Levels in Chronic Myelogenous Leukemia Patients Compared with Normal Subjects

Zahra Shahpouri Arani,
Mohammadreza Hajjari,
Javad Mohammadi Asl,
Najmaldin Saki

Shahpouri Arani Z, Hajjari M, Mohammadi Asl J, Saki N. Upregulation of SNHG7 and FAIM2 Expression Levels in Chronic Myelogenous Leukemia Patients Compared with Normal Subjects. Gene Cell Tissue. 2023;10(2):e131389. doi: https://doi.org/10.5812/gct-131389

2
Jul
2022
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

Nabil W. G. Sweis,
Ahmad Albanna,
Rama Alhasoun,
Ayman Zayed

Sweis NWG, Albanna A, Alhasoun R, Zayed A. A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases. Int J Endocrinol Metab. 2022;20(3):e126350. doi: https://doi.org/10.5812/ijem-126350

More by these authors

Sattar Gorgani FirozjaeiPubMedScholar
Akram NejhadiPubMedScholar
Mohammad SoleimaniPubMedScholar
Radina EshtiaghiPubMedScholar
Share
Cited by
Metrics